- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x PLM: PALMITIC ACID(Non-covalent)
PLM.25: 14 residues within 4Å:- Chain A: T.400, P.401, P.402, P.403, I.404, A.455, Y.456, S.457, M.460, P.502, N.504, Y.505, A.506, Y.559
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:P.402, A:I.404, A:A.455, A:P.502, A:P.502
- Hydrogen bonds: A:S.457, A:Y.559
PLM.39: 15 residues within 4Å:- Chain B: T.400, P.401, P.402, P.403, I.404, K.408, A.455, Y.456, S.457, M.460, P.502, N.504, Y.505, A.506, Y.559
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:P.403, B:A.455, B:Y.456, B:P.502, B:Y.505, B:Y.505, B:A.506
- Hydrogen bonds: B:S.457, B:Y.559
PLM.52: 15 residues within 4Å:- Chain C: T.400, P.401, P.402, P.403, I.404, A.455, Y.456, S.457, M.460, P.502, N.504, Y.505, A.506, Y.507, Y.559
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:T.400, C:P.402, C:P.403, C:I.404, C:A.455, C:P.502, C:P.502, C:Y.505, C:Y.505, C:Y.507
- Hydrogen bonds: C:S.457, C:Y.559
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.26: 2 residues within 4Å:- Chain A: N.73, V.337
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: P.41, E.45, N.111, Q.115
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.132
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.167
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: V.194, I.243, N.244
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: Q.494, N.495
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.590
- Chain B: Y.517
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: E.595, N.617, C.618
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: L.704, N.716
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: N.760
- Chain C: Y.939
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.771
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: N.73, V.337, S.916
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: P.41, N.111, Q.115
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: N.132, N.258
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.167
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: V.194, I.243, N.244
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: Q.494, N.495
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain B: N.590
- Chain C: Y.517
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: N.617, C.618
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain B: L.704, N.716
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain A: Y.939
- Chain B: N.760
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain B: N.771
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: N.73, V.337
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: N.111, Q.115
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.132
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain C: N.167
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain C: I.243, N.244
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain C: Q.494, N.495
Ligand excluded by PLIPNAG.59: 2 residues within 4Å:- Chain A: Y.517
- Chain C: N.590
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain C: N.617
Ligand excluded by PLIPNAG.61: 2 residues within 4Å:- Chain C: L.704, N.716
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain B: Y.939
- Chain C: N.760
Ligand excluded by PLIPNAG.63: 1 residues within 4Å:- Chain C: N.771
Ligand excluded by PLIP- 3 x OLA: OLEIC ACID(Non-covalent)
OLA.37: 14 residues within 4Å:- Chain A: Y.463, S.468, A.469
- Chain C: F.393, Y.417, L.419, L.422, F.426, V.428, F.431, P.438, V.488, F.569, I.571
13 PLIP interactions:12 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:F.393, C:Y.417, C:L.419, C:L.422, C:F.426, C:V.428, C:F.431, C:P.438, C:V.488, C:F.569, C:F.569, C:I.571
- Hydrogen bonds: A:A.469
OLA.38: 16 residues within 4Å:- Chain A: F.393, M.396, Y.417, L.419, L.422, L.423, F.426, V.428, F.431, P.438, L.449, V.451, F.569, I.571
- Chain B: S.468, A.469
14 PLIP interactions:13 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.393, A:L.419, A:L.422, A:L.423, A:F.426, A:V.428, A:P.438, A:L.449, A:V.451, A:F.569, A:F.569, A:F.569, A:I.571
- Hydrogen bonds: B:A.469
OLA.51: 15 residues within 4Å:- Chain B: F.393, Y.417, L.419, L.422, F.426, F.431, P.438, V.451, V.488, F.569, I.571
- Chain C: S.462, S.468, A.469, G.470
13 PLIP interactions:11 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:F.393, B:Y.417, B:L.419, B:L.422, B:F.426, B:P.438, B:V.451, B:V.488, B:V.488, B:F.569, B:F.569
- Hydrogen bonds: C:A.469, C:G.470
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y.Y. et al., Molecular Insights into Species-Specific ACE2 Recognition of Coronavirus HKU5. To Be Published
- Release Date
- 2025-11-05
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x PLM: PALMITIC ACID(Non-covalent)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x OLA: OLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y.Y. et al., Molecular Insights into Species-Specific ACE2 Recognition of Coronavirus HKU5. To Be Published
- Release Date
- 2025-11-05
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C